Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...